The impact of PSMA-positive circulating tumor cells in men with metastatic castrate-resistant prostate cancer (mCRPC)

被引：0
|
作者：
Gupta, S. [1 ]
Yang, Q. [2 ]
Halabi, S. [3 ]
Tubbs, A. [4 ]
Gore, Y. [1 ]
George, D. J. [5 ]
Nanus, D. M. [6 ]
Antonarakis, E. S. [7 ]
Danila, D. [8 ]
Szmulewitz, R. [9 ]
Wenstrup, R. J. [1 ]
Armstrong, A. J. [10 ]
机构：
[1] Epic Sci Inc, Translat Res, San Diego, CA USA
[2] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC USA
[3] Duke Univ Hlth Syst, Biostat & Bioinformat, Durham, NC USA
[4] Epic Sci Inc, Med Off, San Diego, CA USA
[5] Duke Univ, Med Ctr, Dept Med Oncol, Durham, NC USA
[6] Weill Cornell Med Coll, Med, New York, NY USA
[7] Johns Hopkins Univ, Med Oncol, Baltimore, MD USA
[8] MSKCC Mem Sloan Kettering Canc Ctr, GU Med Oncol Dept, New York, NY USA
[9] Univ Chicago, Med Ctr, Hematol Oncol, Chicago, IL USA
[10] Duke Canc Ctr, Med, Durham, NC USA
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1365P
引用
收藏
页码：S1165 / S1166
页数：2
相关论文
共 50 条
  • [1] PSMA-positive Circulating Tumor Cell Detection and Outcomes with Abiraterone or Enzalutamide Treatment in Men with Metastatic Castrate-resistant Prostate Cancer
    Gupta, Santosh
    Halabi, Susan
    Yang, Qian
    Roy, Akash
    Tubbs, Alisa
    Gore, Yamini
    George, Daniel J.
    Nanus, David M.
    Antonarakis, Emmanuel S.
    Danila, Daniel C.
    Szmulewitz, Russell Z.
    Wenstrup, Richard
    Armstrong, Andrew J.
    CLINICAL CANCER RESEARCH, 2023, 29 (10) : 1929 - 1937
  • [2] Impact of comorbidity on outcome in men with metastatic castrate-resistant prostate cancer (mCRPC)
    Zist, A.
    Amir, E.
    Ocana, A.
    Seruga, B.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S703 - S703
  • [3] Metastatic Castrate-Resistant Prostate Cancer (mCRPC)
    Karnes, R. Jeffrey
    Ahmed, Mohamed E.
    APPLIED RADIOLOGY, 2021, 50 (01) : 42 - 43
  • [4] Analysis of the prognostic significance of circulating tumor DNA (ctDNA) in metastatic castrate-resistant prostate cancer (mCRPC)
    Shaya, Justin
    Randall, James Michael
    Millard, Frederick E.
    Kurzrock, Razelle
    Parsons, J. Kellogg
    Tamayo, Pablo
    McKay, Rana R.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [5] Recovery and characterization of circulating tumor cells (CTCs) in cryopreserved metastatic castrate-resistant prostate cancer (mCRPC) patient samples
    Lu, David
    Harvey, Melissa
    Madan, Ravi
    Heery, Christopher
    Marte, Jennifer
    Beasley, Sharon
    Landers, Mark
    Krupa, Rachel
    Louw, Jessica
    Wahl, Justin
    Bales, Natalee
    Marrinucci, Dena
    Schlom, Jeffrey
    Gulley, James
    Dittamore, Ryan
    CANCER RESEARCH, 2015, 75
  • [6] The impact of circulating tumor cell HOXB13 RNA detection in men with metastatic castrate-resistant prostate cancer (mCRPC) treated with abiraterone or enzalutamide
    Guo, Siyuan S.
    Halabi, Susan
    Nanus, David M.
    George, Daniel J.
    Antonarakis, Emmanuel S.
    Danila, Daniel Costin
    Szmulewitz, Russell Zelig
    McDonnell, Donald P.
    Norris, John D.
    Lu, Changxue
    Luo, Jun
    Armstrong, Andrew J.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [7] Impact of race on outcomes to 177Lu-PSMA-617 (LuPSMA) for metastatic castrate-resistant prostate cancer (mCRPC).
    Rami, Avina
    Ng, Thomas S. C.
    Rothmann, Emily
    Stoltenberg, Hailey
    Wolanski, Andrew
    Ritzer, Jolivette
    Choudhury, Atish Dipankar
    Gao, Xin
    Haberman, Veronica
    Kako, Bashar
    Kilbridge, Kerry L.
    Morgans, Alicia K.
    O'Shea, Aileen
    Taplin, Mary-Ellen
    Jacene, Heather
    Ravi, Praful
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 27 - 27
  • [8] Timing of docetaxel chemotherapy and impact on outcomes in metastatic castrate-resistant prostate cancer (MCRPC).
    Thomson, Alastair
    Pollard, Adam
    Mark, Frances May
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [9] PSMA heterogeneity analysis in patients with metastatic castrate-resistant prostate cancer (mCRPC): Imaging versus CTCs.
    Morris, Michael J.
    Vogelzang, Nicholas J.
    Sartor, A. Oliver
    Armour, Alison A.
    Messmann, Richard Adam
    Groaning, Michael
    Robarts, Adam
    Tolcher, Anthony W.
    Gordon, Michael S.
    Babiker, Hani M.
    Kuo, Phillip
    Kearney, Megan
    Jendrisak, Adam
    Wang, Yipeng
    Landers, Mark Andrew
    Petrylak, Daniel Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [10] The impact of sarcopenia on clinical outcomes in men with metastatic castrate-resistant prostate cancer
    Papadopoulos, Efthymios
    Wong, Andy Kin On
    Law, Sharon Hiu Ching
    Zhang, Lindsey Ze Jing
    Breunis, Henriette
    Emmenegger, Urban
    Alibhai, Shabbir M. H.
    PLOS ONE, 2023, 18 (06):
12345